Certain doses of Eli Lilly's (LLY) GLP-1 weight loss drugs Zepbound and Mounjaro are facing a supply shortage, much like competitor Novo Nordisk's (NVO) own ...
) own weight-loss treatment Wegovy. Eli Lilly is now considering releasing vials of their treatments for consumers capable of self-administering the drug. TheHost Dave Knapp talks about his experience using various treatment methods after a Type 2 Diabetes diagnosis and the major supply and demand imbalances occurring around the pharmaceutical trend.
And so really what I sought out to do.
So I myself have had to step back in doses. I've been very fortunate to have doctors who are willing to put in the effort and energy to advocate for me and help me find the branded versions. It's getting harder and harder, though.
Novo Nordisk Supply Shortage Weight Loss Pharmaceutical Company
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly and Novo Nordisk's Diabetes Drugs Being Studied for Other Health BenefitsEli Lilly's Mounjaro and Novo Nordisk's Ozempic and Wegovy are being investigated for potential health benefits beyond diabetes treatment. A study is examining whether Novo's Wegovy can reduce alcohol intake in patients with early Alzheimer's disease. Another study is testing Novo's semaglutide in combination with clot removal therapy for stroke patients. Lilly is also conducting research on the effects of their drugs on Alzheimer's disease and obesity.
Read more »
Amazon, Rite Aid Can’t Get Enough Supply of Weight-Loss Drug ZepboundRite Aid Corp. and Amazon Pharmacy confirmed that Eli Lilly & Co.’s new weight-loss drug Zepbound is in short supply, as patient, pharmacist and doctor complaints mount.
Read more »
Lilly’s $2.5 Billion German Plant Will Boost Obesity-Drug SupplyEli Lilly & Co. kicked off construction of a plant to boost the production of its wildly popular weight-loss drugs, which have yet to gain a foothold in Europe.
Read more »
Medicare can pay for obesity drugs like Wegovy in certain heart patientsMedicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future...
Read more »
Vaughan bylaw proposal aims to restrict protests near certain sitesMayor Steven Del Duca needs the support of Vaughan council for his member’s resolution to become a bylaw
Read more »
Trailblazing cellular biologist Connie Eaves explored the origins of certain cancersA professor at UBC and distinguished scientist at B.C. Cancer Agency’s Terry Fox Laboratory, she made key discoveries about leukemia and breast malignancies that led to new approaches for treatment, and she advocated for women in science
Read more »